top of page

High-growth, GACP/EU-GMP pharma cannabis company in Portugal seeks strategic partner

Established EU-GMP-certified cannabis company in Portugal with state-of-the-art indoor cultivation facility seeking strategic equity partner to support its next phase of growth.

Listing ID:

27439455091

Licence(s) Held:

GACP license and EU-GMP certification from INFARMED

27439455091

Seeking strategic equity partner to invest €5.5 million at a €12.8 million pre-money valuation

Listing Details:

  • Established, Portuguese pharmaceutical cannabis company positioned to grow rapidly and meet the stringent quality requirements of international medical cannabis markets

  • Company is completing a binding transaction for the full acquisition of a well-established business with a state-of-the-art, 5,000 m² GACP/EU-GMP-certified indoor facility in Portugal

  • Facility features multiple GACP cultivation rooms, EU-GMP-compliant post-harvesting areas for drying, trimming, and an R&D lab

  • Business has been operational since 2020 and achieved GMP certification in 2023, able to produce 2,000 KG/yr of craft quality cannabis (with expansion capacity to 10,000 KG)

  • Secured multi-year supply contracts projected to generate total revenue of €30M+

  • Existing distribution and commercial agreements in place with key markets, including Germany, Poland, Portugal, Switzerland, and Australia, with ongoing entry into the UK market

  • The production capacity of Phase 1 is fully fulfilled, driving the need to accelerate the expansion plan to address growing demand.

  • There is an option to leverage another facility owned by affiliated stakeholders, creating capacity for a strategic partner to utilize part of the company’s facility's overall production capabilities

  • Team with deep expertise in the cannabis and pharma sectors with access to a network of licensed facilities in Europe and the US, and executives from the big pharma industry

  • Site has an approved expansion plan to scale up to 10,000 kg per year (permit already secured for the extension facility) projected to generate €30 million+ of revenue per year

  • Site features installed solar panels delivering up to 35% annual electricity savings while promoting sustainability

  • Development plan to acquire a distributor in European key market, projected to generate >€50 million of revenue per year overall.

  • This opportunity seeks a strategic equity partner to accelerate growth plans.

27439455091

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal
bottom of page